Decreased protein expression levels, including p-STAT3/STAT3and Bcl-2/Bax, were observed following treatment with CSF1R inhibitor (Figure 6B), suggesting that the IL-34/CSF-1R/STAT3 pathway is involved in the apoptosis resistance of thyrocytes in HT. This evidence concerns the gene BCL2 and hematocrit.